Pharmaceutical Emulsions: A Viable Approach for Ocular Drug Delivery.

Ocular disorders can lead to serious sight impairment and irreversible blindness. Generally simple topical and systemic treatments are recommended for treating these vision-threatening illnesses. The distinctive architecture of the eye complicates ocular drug delivery. The ophthalmic emulsion formulations have been found to increase bioavailability in the eye by prolonging residence time and improving permeability through the cornea. Therefore, this study highlights ophthalmic emulsions meant for both the anterior and posterior parts of the eye while examining a wide range of ocular disorders that affect individuals globally. This review presents, in brief, recent emulsion-based patented innovations, clinical trials, and marketed emulsion formulations for ocular drug delivery, which are strengthening development of the new ophthalmic drug products for managing different ocular diseases and disorders.

[1]  R. Bhatta,et al.  Solanum nigrum Toxicity and Its Neuroprotective Effect Against Retinal Ganglion Cell Death Through Modulation of Extracellular Matrix in a Glaucoma Rat Model. , 2024, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[2]  R. Bhatta,et al.  Ocular bioanalysis of moxifloxacin and ketorolac tromethamine in rabbit lacrimal matrix using liquid chromatography-tandem mass spectrometry. , 2024, Bioanalysis.

[3]  Mukesh Kumar,et al.  Simultaneous determination of amphotericin B, tobramycin and vancomycin in rabbit ocular biofluids and tissues by LC-MS/MS: An antimicrobial therapy for keratitis and its PK-PD application. , 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  Mukesh Kumar,et al.  Concurrent determination of anti-microbial and anti-inflammatory drugs in lachrymal fluid and tissue by LC-MS/MS: A potential treatment for microbial keratitis and its PK-PD evaluation. , 2023, Journal of pharmaceutical and biomedical analysis.

[5]  R. Bhatta,et al.  Trends in Formulation Approaches for Sustained Drug Delivery to the Posterior Segment of the Eye , 2023, AAPS PharmSciTech.

[6]  K. Yadav,et al.  Microemulsions for Enhancing Drug Delivery of Hydrophilic Drugs: Exploring Various Routes of Administration , 2023, Medicine in Drug Discovery.

[7]  Mukesh Kumar,et al.  Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management. , 2023, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[8]  D. Ghiglioni,et al.  Vernal Keratoconjunctivitis: A Systematic Review , 2023, Clinical Reviews in Allergy & Immunology.

[9]  Xu Liu,et al.  Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment. , 2023, Journal of controlled release : official journal of the Controlled Release Society.

[10]  R. Bhatta,et al.  Ophthalmic nano-bioconjugates: critical challenges and technological advances. , 2023, Therapeutic delivery.

[11]  Yao Fu,et al.  Nanotechnology-based ocular drug delivery systems: recent advances and future prospects , 2023, Journal of Nanobiotechnology.

[12]  Mukesh Kumar,et al.  A QbD-led Simple and Sensitive RP-UHPLC method for Simultaneous Determination of Moxifloxacin, Voriconazole, and Pirfenidone: An Application to Pharmaceutical Analysis. , 2023, Biomedical chromatography : BMC.

[13]  R. Bhatta,et al.  Simultaneous estimation of voriconazole, moxifloxacin, and pirfenidone in rabbit lacrimal matrix using LC-MS/MS: an application to preclinical ocular pharmacokinetics. , 2023, Analytical methods : advancing methods and applications.

[14]  Yanna Zhao,et al.  Comparative study of cyclosporine A liposomes and emulsions for ophthalmic drug delivery: Process optimization through response surface methodology (RSM) and biocompatibility evaluation. , 2023, Colloids and surfaces. B, Biointerfaces.

[15]  R. K. Ameta,et al.  Recent Advances in Improving the Bioavailability of Hydrophobic/Lipophilic Drugs and Their Delivery via Self-Emulsifying Formulations , 2023, Colloids and Interfaces.

[16]  M. Amin,et al.  Ocular Drug Delivery: a Comprehensive Review , 2023, AAPS PharmSciTech.

[17]  S. Safi,et al.  Systematic review of clinical practice guidelines for uveitis , 2023, BMJ Open Ophthalmology.

[18]  R. Bhatta,et al.  Liquid chromatography‐tandem mass spectrometry method for simultaneous assessment of ofloxacin and dexamethasone in ocular biofluids: Application to ocular pharmacokinetic studies , 2022, SEPARATION SCIENCE PLUS.

[19]  C. Y. Chee,et al.  Review of Functional Aspects of Nanocellulose-Based Pickering Emulsifier for Non-Toxic Application and Its Colloid Stabilization Mechanism , 2022, Molecules.

[20]  R. Agrawal,et al.  Nonsurgical Management of Severe Viral Keratitis with Hypopyon and Retrocorneal Plaques: A Case Series , 2022, Ophthalmology and Therapy.

[21]  Anroop B Nair,et al.  Enhanced anti-cataract effect of microemulsion containing Cineraria maritima: Formulation, optimization and in vivo evaluation , 2022, Journal of Drug Delivery Science and Technology.

[22]  S. Chopra,et al.  Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis. , 2022, International journal of biological macromolecules.

[23]  Arash Omidtabrizi,et al.  Acute retinal necrosis. Management and visual outcomes: a case series , 2022, International Journal of Retina and Vitreous.

[24]  R. Bhatta,et al.  A recent update on therapeutic potential of vesicular system against fungal keratitis , 2022, Journal of Drug Delivery Science and Technology.

[25]  A. Fea,et al.  Glaucoma Treatment and Hydrogel: Current Insights and State of the Art , 2022, Gels.

[26]  Shinji Watanabe,et al.  Applications of Medium-Chain Triglycerides in Foods , 2022, Frontiers in Nutrition.

[27]  S. Chopra,et al.  QbD based antifungal drug-loaded ophthalmic liposomal formulation for the management of fungal keratitis: In vitro, ex vivo and in vivo pharmacokinetic studies , 2022, Journal of Drug Delivery Science and Technology.

[28]  S. Karthikeyan,et al.  Novel angular binary pattern (NABP) and kernel based convolutional neural networks classifier for cataract detection , 2022, Multimedia Tools and Applications.

[29]  Prawej Ansari,et al.  Diabetic Retinopathy: An Overview on Mechanisms, Pathophysiology and Pharmacotherapy , 2022, Diabetology.

[30]  Mohammad Y. Alshahrani,et al.  Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System , 2022, Gels.

[31]  J. Manwar,et al.  A CRITICAL REVIEW ON NANOEMULSION: ADVANTAGES, TECHNIQUES AND CHARACTERIZATION , 2022, Journal of Applied Pharmaceutical Sciences and Research.

[32]  J. Walsh,et al.  Targeting Ocular Drug Delivery: An Examination of Local Anatomy and Current Approaches , 2022, Bioengineering.

[33]  K. B. Shah,et al.  Cyclosporine release and distribution in ophthalmic emulsions determined by pulsatile microdialysis. , 2022, International journal of pharmaceutics.

[34]  Jian-xing Ma,et al.  Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization , 2021, Biology.

[35]  R. Bhatta,et al.  Simultaneous determination of fluconazole and ofloxacin in rabbit tear fluid by LC-MS/MS: Application to ocular pharmacokinetic studies. , 2021, Journal of pharmaceutical and biomedical analysis.

[36]  J. Grauslund,et al.  Topical treatment of diabetic retinopathy: a systematic review , 2021, Acta ophthalmologica.

[37]  Mohammad Mehdi Mahboobian,et al.  Acyclovir-Loaded Nanoemulsions: Preparation, Characterization and Irritancy Studies for Ophthalmic Delivery , 2021, Current eye research.

[38]  C. Strachan,et al.  Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin , 2021, Pharmaceutics.

[39]  Mohammad Mehdi Mahboobian,et al.  Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation , 2021, Drug Delivery and Translational Research.

[40]  J. Hadžiabdić,et al.  Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions , 2020, Pharmaceutics.

[41]  A. Bernkop‐Schnürch,et al.  Strategies to prolong the residence time of drug delivery systems on ocular surface. , 2020, Advances in colloid and interface science.

[42]  P. Shukla,et al.  Topical corneal targeted sustained release amphotericin B liposomal formulation for the treatment of fungal keratitis and its PK-PD evaluation , 2020 .

[43]  J. Jägers,et al.  Perfluorocarbon-based oxygen carriers: from physics to physiology , 2020, Pflügers Archiv - European Journal of Physiology.

[44]  S. Kang,et al.  Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[45]  C. Regatieri,et al.  Age-related macular degeneration: a review of current therapies and new treatments. , 2020, Arquivos brasileiros de oftalmologia.

[46]  A. Al-Nima,et al.  Nanoemulsions as Ophthalmic Drug Delivery Systems , 2020, Turkish journal of pharmaceutical sciences.

[47]  S. Pflugfelder,et al.  Biological functions of tear film. , 2020, Experimental eye research.

[48]  Vivek,et al.  Role of Micro Emulsion Based In-Situ Gelling System of Fluoroquinolone for Treatment of Posterior Segment Eye Diseases (PSED) , 2020 .

[49]  P. Siafaka,et al.  Novel Ocular Drug Delivery Systems: An Update on Microemulsions. , 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[50]  Minxin Zhang,et al.  Cationic Nanoemulsions with Prolonged Retention Time as Promising Carriers for Ophthalmic Delivery of Tacrolimus. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[51]  Lucia Pavoni,et al.  An Overview of Micro- and Nanoemulsions as Vehicles for Essential Oils: Formulation, Preparation and Stability , 2020, Nanomaterials.

[52]  M. Lake,et al.  A Supersaturated Oxygen Emulsion for the Topical Treatment of Ocular Trauma. , 2019, Military medicine.

[53]  M. Pellegrini,et al.  Assessment of Corneal Fluorescein Staining in Different Dry Eye Subtypes Using Digital Image Analysis , 2019, Translational vision science & technology.

[54]  E. Sánchez-López,et al.  Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents , 2019, Pharmaceutics.

[55]  N. Biswas,et al.  Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits , 2019, Journal of basic and clinical physiology and pharmacology.

[56]  Pierre P. D. Kondiah,et al.  Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery , 2019, Polymers.

[57]  Hari Prasad Devkota,et al.  Medicinal Plants and Natural Products Used in Cataract Management , 2019, Front. Pharmacol..

[58]  Md. Akhlaquer Rahman,et al.  Nanoemulsion: Promising nanocarrier system for delivery of herbal bioactives , 2019, Journal of Drug Delivery Science and Technology.

[59]  J. Németh,et al.  A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. , 2019, Ophthalmology.

[60]  N. Anton,et al.  Double emulsions prepared by two–step emulsification: History, state‐of‐the‐art and perspective , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[61]  A. Mitra,et al.  Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease , 2019, Pharmaceutical Research.

[62]  Sangsub Jung,et al.  High-throughput toxicity study of lubricant emulsions and their common ingredients using zebrafish , 2018, PloS one.

[63]  O. Martín‐Belloso,et al.  Beverage Emulsions: Key Aspects of Their Formulation and Physicochemical Stability , 2018, Beverages.

[64]  C. Georgakopoulos,et al.  An eye for azithromycin: review of the literature , 2018, Therapeutic advances in ophthalmology.

[65]  Arturo Santos,et al.  Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery. , 2018, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[66]  Rahul Tiwari,et al.  Therapeutic challenges in ocular delivery of lipid based emulsion , 2018, Egyptian Journal of Basic and Applied Sciences.

[67]  Rinda Devi Bachu,et al.  Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases , 2018, Pharmaceutics.

[68]  Sheridan M. Hoy Ciclosporin Ophthalmic Emulsion 0.1%: A Review in Severe Dry Eye Disease , 2017, Drugs.

[69]  R. Gurny,et al.  Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[70]  K. Shah,et al.  Emulsion of Chloramphenicol: an Overwhelming Approach for Ocular Delivery , 2017, Folia medica.

[71]  Eun Seong Lee,et al.  Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye drops , 2016 .

[72]  S. Deore,et al.  Emulsion Micro Emulsion and Nano Emulsion: A Review , 2016 .

[73]  Animikh Ray,et al.  A comprehensive insight on ocular pharmacokinetics , 2016, Drug Delivery and Translational Research.

[74]  H. Takeuchi,et al.  Effect of high-pressure homogenization on stability of emulsions containing zein and pectin , 2016, Asian journal of pharmaceutical sciences.

[75]  R. Rejdak,et al.  Drug bioavailability from topically applied ocular drops. Does drop size matter , 2016 .

[76]  A. Mitra,et al.  Novel strategies for the treatment of diabetic macular edema , 2016 .

[77]  H. Lew,et al.  Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy , 2016, Korean journal of ophthalmology : KJO.

[78]  Sharul Sham Dol,et al.  Crude oil emulsion: A review on formation, classification and stability of water-in-oil emulsions , 2015 .

[79]  T. Wong,et al.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss , 2015, Eye and Vision.

[80]  A. Galor,et al.  Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence. , 2015, Clinical investigation.

[81]  Dawood Aghadoost Ocular Trauma: An Overview , 2014, Archives of trauma research.

[82]  J. Pluta,et al.  Ophthalmic Drug Dosage Forms: Characterisation and Research Methods , 2014, TheScientificWorldJournal.

[83]  Amitava Ghosh,et al.  Microemulsion: New Insights into the Ocular Drug Delivery , 2013, ISRN pharmaceutics.

[84]  A. Mitra,et al.  Ocular drug delivery systems: An overview. , 2013, World journal of pharmacology.

[85]  A. Mitra,et al.  Novel strategies for anterior segment ocular drug delivery. , 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[86]  P. Daull,et al.  A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[87]  F. Lallemand,et al.  Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, Novasorb , 2012, Journal of drug delivery.

[88]  C. Foster,et al.  Difluprednate for inflammatory eye disorders. , 2011, Drugs of today.

[89]  Terry Kim,et al.  Anatomy and physiology of the cornea , 2011, Journal of cataract and refractive surgery.

[90]  S. Majumdar,et al.  Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.

[91]  A. Mitra,et al.  Ocular Drug Delivery , 2010, The AAPS Journal.

[92]  H. Yamashita,et al.  Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[93]  Maria Jose Alonso,et al.  Chitosan-based nanostructures: a delivery platform for ocular therapeutics. , 2010, Advanced drug delivery reviews.

[94]  D. Callanan,et al.  The role of difluprednate ophthalmic emulsion in clinical practice , 2009, Clinical ophthalmology.

[95]  Xing Tang,et al.  Lipid emulsions as a potential delivery system for ocular use of azithromycin , 2009, Drug development and industrial pharmacy.

[96]  Y. Chevalier,et al.  Topical delivery of lipophilic drugs from o/w Pickering emulsions. , 2009, International journal of pharmaceutics.

[97]  Jim Jiao Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. , 2008, Advanced drug delivery reviews.

[98]  Sushma Talegaonkar,et al.  Development and bioavailability assessment of ramipril nanoemulsion formulation. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[99]  C. Klaver,et al.  Age-related macular degeneration , 2006, BMJ : British Medical Journal.

[100]  S. Best Glaucoma Diagnosis and Management , 2006 .

[101]  A. Mitra,et al.  Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea. , 2006, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[102]  T. Rades,et al.  W/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[103]  Makiko Yamamoto,et al.  Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. , 2005, International journal of pharmaceutics.

[104]  Simon Benita,et al.  The potential of lipid emulsion for ocular delivery of lipophilic drugs. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[105]  H. Shichi Cataract formation and prevention , 2004, Expert opinion on investigational drugs.

[106]  S. Dinslage,et al.  A comparative bioavailability study of three conventional eye drops versus a single lyophilisate , 2003, The British journal of ophthalmology.

[107]  S. Perfetti,et al.  Glaucoma and quality of the life , 1998, Acta ophthalmologica Scandinavica. Supplement.

[108]  D. Brossard,et al.  Amphotericin B eye drops as a lipidic emulsion , 1996 .

[109]  S. Nazir,et al.  Chloramphenicol Loaded Microemulsions: Development, Characterization and Stability , 2019, Colloid and Interface Science Communications.

[110]  S. Doktorovová,et al.  Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular delivery , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[111]  R. Moots,et al.  Behcet's disease , 2017, Clinical medicine.

[112]  A. Acheampong,et al.  Ocular Pharmacokinetics and Safety of Ciclosporin, a Novel Topical Treatment for Dry Eye , 2005, Clinical pharmacokinetics.

[113]  J. W. Shell Ocular Drug Delivery Systems - A Review , 1982 .